The Macerich Company

NYSE:MAC Rapport sur les actions

Capitalisation boursière : US$6.5b

Macerich Croissance future

Future contrôle des critères 3/6

Macerich devrait augmenter ses bénéfices et son chiffre d'affaires de 84.7% et de 1.1% par an respectivement. Le BPA devrait croître de de 84.4% par an. Le rendement des capitaux propres devrait être 1.4% dans 3 ans.

Informations clés

84.7%

Taux de croissance des bénéfices

84.36%

Taux de croissance du BPA

Retail REITs croissance des bénéfices-2.0%
Taux de croissance des recettes1.1%
Rendement futur des capitaux propres1.36%
Couverture par les analystes

Good

Dernière mise à jour21 May 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • May 24

MAC: Equity Raise And Execution Risks Will Cap Future Upside Potential

Analysts have lifted the price target on Macerich to $19.00 from $15.58, citing refreshed models that reflect updated guidance, adjusted expectations for revenue decline and margins, and a range of recent price target increases across the Street. Analyst Commentary Recent Street research around Macerich points to a mix of optimism on execution and balance sheet progress, alongside ongoing debate about how fully the stock already reflects these improvements.
Mise à jour du récit • May 07

MAC: Path Forward Execution And Deleveraging May Support Balanced Repricing Ahead

Analysts have raised their average price target for Macerich by a few dollars to reflect recent target increases across several research firms, citing progress on the company's multi year "Path Forward Plan," asset sales, and balance sheet improvement as key supports for the updated view. Analyst Commentary Recent research updates present a mixed picture on Macerich, with several price target increases and a couple of rating changes that highlight both improving execution and ongoing debates about valuation and risk.
Mise à jour du récit • Apr 20

MAC: Path Forward Execution And Deleveraging Support Balanced Outlook As Models Update

The analyst price target for Macerich edges up from $21.38 to $21.63, as analysts factor in a modestly lower discount rate, steady revenue and margin assumptions, and recent Street research that highlights execution on the "Path Forward Plan," asset sales, deleveraging, and updated valuation models across several firms. Analyst Commentary Recent Street research on Macerich reflects a mix of optimism about the company’s execution and balance sheet progress, alongside ongoing caution on valuation and long term earnings power.
Mise à jour du récit • Apr 05

MAC: Path Forward Execution And Deleveraging Shape Balanced Outlook For Future Returns

Analysts nudged Macerich's fair value estimate to $21.38 from $21.19, citing updated models that reflect improved profit margin assumptions, a lower discount rate, and recent price target increases across the Street. Analyst Commentary Recent Street research on Macerich clusters around higher price targets and rating changes, with opinions split between optimism on execution and caution on valuation and sector fundamentals.
Mise à jour du récit • Mar 21

MAC: Path Forward Deleveraging And Asset Sales Will Drive Future Returns

The analyst price target for Macerich increases from $21.13 to $21.19 as analysts factor in updated models, recent price target revisions across the Street, and progress against the company's multi-year "Path Forward Plan." Analyst Commentary Recent research updates on Macerich reflect a mix of optimism around execution on the "Path Forward Plan" and caution on valuation and sector fundamentals. Price targets now span from the high teens to the mid twenties, with ratings ranging from Sell to Overweight.
Mise à jour du récit • Mar 07

MAC: Path Forward Execution And Deleveraging Will Shape Future Returns

The analyst price target for Macerich has moved higher to $21.13 from $20.13 as analysts point to updated expectations for the company’s Path Forward Plan, improving margin assumptions and revised P/E and discount rate inputs in recent research. Analyst Commentary Recent Street research on Macerich shows a mix of optimism around execution on the Path Forward Plan and caution around valuation and sector headwinds.
Mise à jour du récit • Feb 20

MAC: Peak Fundamentals And Occupancy Levels Will Limit Future Upside Potential

Analysts have lifted their price targets on Macerich, including one increase to $21. This change reflects updated views on discount rates, revenue trends, profit margins, and future P/E assumptions.
Mise à jour du récit • Feb 06

MAC: Sector Peak Concerns And Occupancy Expectations Will Shape Future Returns

Analysts have nudged their fair value estimate for Macerich up from about $19.86 to $20.13, citing a series of recent price target increases and updated sector views that reflect current expectations for occupancy and earnings quality. Analyst Commentary Bullish Takeaways Bullish analysts highlight the series of price target resets, from US$18 to US$19 and then above US$20, as support for a modestly higher fair value range for the shares.
Seeking Alpha • Feb 03

Macerich: Deleveraging Balance Sheet And Redevelopments To Limit Downside Risk

Summary Macerich is reiterating its multi-year "Path Forward Plan" transformation strategy to sell non-core properties to reduce debt. I downgrade MAC to Hold from Buy, as the shares are currently trading above my calculated intrinsic NAV of $15.42. Cap rate compression could happen with improved portfolio quality and reduced debt in the future. Read the full article on Seeking Alpha
Mise à jour du récit • Jan 22

MAC: Peak Occupancy Concerns Will Constrain Future Upside Potential

Narrative update on Macerich Analysts have nudged their fair value estimate for Macerich to about US$15.58 from US$15.00, reflecting recent price target increases across the Street as they refresh assumptions on growth, margins and long term P/E expectations. Analyst Commentary Recent Street research on Macerich has centered on refreshed price targets and sector views as firms revisit their models for U.S. real estate and REITs. While individual targets differ, the common thread is a reassessment of mall and shopping center fundamentals alongside updated assumptions for occupancy and earnings power.
Mise à jour du récit • Jan 08

MAC: Lower Discount Rate And P/E Assumptions Will Shape Future Returns

Narrative update on Macerich Analysts have lifted their price target on Macerich to about $19.86 from $19.53, reflecting updated views on discount rates, revenue trends, margins and long term P/E assumptions, in line with recent Street research that raised one target to $19. Analyst Commentary Recent commentary focuses on how updated discount rates, revenue trends, margin assumptions and long term P/E expectations feed into the fair value range for Macerich.
Mise à jour du récit • Sep 20

Experiential Retail Trends Will Revitalize Urban Leasing

Analysts modestly increased Macerich’s price target to $19.53, citing improved Q2 performance and a sector-wide REIT valuation reassessment, though concerns about the company’s risk profile persist. Analyst Commentary Bullish analysts increased price targets following updated financial models that reflect improved Q2 performance.
User avatar
Nouveau récit • Feb 10

Rising Interest Rates And Debt Reduction Plans May Erode Future Earnings

Reducing debt and strategic asset sales may cause revenue instability and transitional earnings impacts during restructuring efforts.
Seeking Alpha • Jan 07

Is Macerich Now A Buy?

Summary Macerich has rallied heavily over the last year as market enthusiasm builds over its Path Forward Plan. The REIT is currently trading for 13.5x times its annualized third-quarter FFO and offers a modest 3.31% dividend yield. The November equity offering should be accretive, but revenue is set to dip in future quarters on asset sales and givebacks. Read the full article on Seeking Alpha
Seeking Alpha • Oct 16

Macerich: Old Retail Is Fading

Summary Macerich is a REIT focused on malls and shopping centers, currently yielding 3.8%, with no clear growth story. Management aims to reduce debt by $2B through asset sales, but this likely means revenue and cash flows will decline in the near term. E-commerce growth and the shift from brick-and-mortar retail present significant challenges, making MAC's turnaround and profitable growth uncertain. Read the full article on Seeking Alpha
Seeking Alpha • Aug 01

Macerich: Probability Of Better Dividends Is Weak

Summary MAC reported FFO numbers for its second quarter that dipped 1 cent per share year-over-year. The dividend is 230% covered by FFO but still sits almost 80% below its pre-pandemic level. Management has not made it clear that their path forward plan intends to boost the capacity for more substantial dividend payouts. Read the full article on Seeking Alpha
Seeking Alpha • May 01

Macerich: Increased Headwinds And Higher Valuation Reduce Investment Appeal (Rating Downgrade)

Summary Macerich's Q1 2024 results were below expectations, with a big miss on funds from operations (FFO) and a slight decrease in same center net operating income (NOI). The company faces persistent challenges including high interest rates, a weakened consumer, and increased competition from online retailers and overseas markets, all of which are pressuring traditional mall revenues. Refinancing debt at higher interest rates and pressures on consumer spending further contribute to the company's challenges. Read the full article on Seeking Alpha

Prévisions de croissance des bénéfices et des revenus

NYSE:MAC - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202899833N/A3894
12/31/202796311193336
12/31/2026940-45703047
3/31/20261,024-184310310N/A
12/31/20251,041-198322322N/A
9/30/20251,100-390326326N/A
6/30/20251,049-411314314N/A
3/31/20251,012-118311311N/A
12/31/2024899-195283283N/A
9/30/202478878278278N/A
6/30/2024794-76285285N/A
3/31/2024839-343276276N/A
12/31/2023856-275296296N/A
9/30/2023879-335299299N/A
6/30/2023878-88361361N/A
3/31/2023832-88353353N/A
12/31/2022866-67338338N/A
9/30/2022844-86360360N/A
6/30/202283836289289N/A
3/31/202286340300300N/A
12/31/202186813286286N/A
9/30/2021823-160271271N/A
6/30/2021786-289253253N/A
3/31/2021715-302127127N/A
12/31/2020759-231125125N/A
9/30/2020831-14148148N/A
6/30/202090454175175N/A
3/31/202097495306306N/A
12/31/201997696N/A355N/A
9/30/201998781N/A369N/A
6/30/2019997108N/A345N/A
3/31/20191,016100N/A348N/A
12/31/20181,02859N/A344N/A
9/30/20181,04680N/A334N/A
6/30/20181,04724N/A361N/A
3/31/20181,04943N/A379N/A
12/31/20171,044145N/A386N/A
9/30/20171,060150N/A398N/A
6/30/20171,066146N/A400N/A
3/31/20171,080165N/A412N/A
12/31/20161,085516N/A430N/A
9/30/20161,131893N/A458N/A
6/30/20161,204913N/A487N/A
3/31/20161,261882N/A498N/A
12/31/20151,322486N/A555N/A
9/30/20151,3231,500N/A517N/A
6/30/20151,2671,503N/A483N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: MAC devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 3.5% ).

Bénéfices vs marché: MAC devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: MAC devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de MAC ( 1.1% par an) devrait croître plus lentement que le marché de US ( 11.7% par an).

Croissance élevée des revenus: Le chiffre d'affaires de MAC ( 1.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de MAC devrait être faible dans 3 ans ( 1.4 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/25 21:00
Cours de l'action en fin de journée2026/05/22 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

The Macerich Company est couverte par 36 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
null nullArgus Research Company
Ross SmotrichBarclays
Paul AdornatoBMO Capital Markets Equity Research